Ventiv's Clinical Services division has joined with India's largest
domestic contract research organization (CRO), SIRO Clinpharm, to
provide India-based clinical data management services, offering
pharma and biotech companies...
Near-infrared (NIR) chemical imaging is emerging as the analytical
tool of choice for drug formulation development, analysis and
process monitoring of the increasing number of advanced drug
Medical Services International (MSI) has been contracted by a
Chinese corporation to produce a potentially life-saving diagnostic
test kit for avian flu that will give test results in 30 minutes
instead of the current three days.
Premier Research has continued its spate of acquisitions this year,
with the latest addition of clinical research organization (CRO)
Imform, which will aid the company's expansion plans into Eastern
India's Ranbaxy Laboratories has been granted a US patent on its
controlled-release drug delivery system, which takes the form of a
'floating' tablet that once swallowed, is retained in the upper
The European Commission has profiled the top 100 biotech technology
offers in a new brochure, which showcases the offers in such a way
that encourages European researchers to pursue the exploitation of
their own research results.
Omnicare will soon be offering staff that are "eClinical trained"
as a strategic tool to woo clinical trial contracts and compete
with services offered by rival contract research organizations
(CROs) such as Quintiles.
SRA International has received a $15 million outsourcing contract
from the National Institutes of Health (NIH) to provide enterprise
messaging and IT infrastructure support services over the next 6
Drug production company Patheon has released its fourth-quarter
results, which has revealed that profit has jumped 180 per cent
despite a recent production halt at a Puerto Rican subsidiary. This
bodes well for the recent manufacturing...
Shanghai-based biotech company WuXi PharmaTech has grown more than
100 times in the last 5 years after operating successfully in
China's infant biotech industry by providing variety of outsourcing
services in drug R&D.
Ventiv health reported a strong performance across all its business
units in the third quarter, with total revenues increasing by 44
per cent to $128.4 million (€107.6 million) compared to the third
quarter of 2004.